News
Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...
Investor's Business Daily on MSN25m
Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback